(1S,2R)-N-Benzyl-2-Amino-1,2-Diphenylethanol: Real Value in Advanced Synthesis

Product Introduction—A Chemist’s View

Working at the bench and in kilogram batches, we understand the difference that a precise chiral building block brings to a synthetic campaign. Among our catalog, (1S,2R)-N-Benzyl-2-Amino-1,2-Diphenylethanol has earned a regular spot on workbenches for a reason. It offers utility beyond what ordinary amino alcohols bring, thanks to its solid stereochemical control, trustworthy purity, and efficient compatibility with asymmetric synthesis. Chemically, this molecule balances a rigid frame from its two phenyl groups with functional reactivity. It's favored in our lab both as a standalone intermediate and, more often, as a linchpin for key steps in complex molecule construction.

What Sets (1S,2R)-N-Benzyl-2-Amino-1,2-Diphenylethanol Apart?

Through our hands-on manufacturing, we’ve seen countless batches of chiral amino alcohols pass through reactors and columns. Not every compound stands apart in both ease of handling and downstream performance. This particular enantiomer, with the (1S,2R) configuration, has shown crisp, dependable behavior in coupling reactions, chiral auxiliary roles, and protecting group strategies. The benzyl substitution on nitrogen ups its reactivity profile compared with non-benzylated analogs, facilitating versatility when building out heterocycles or attaching sensitive side chains.

From the ground up, the difference comes down to control. We run multiple stage checks for stereochemical retention, since even subtle racemization torpedoes downstream yields. With this product, we consistently see sharp optical rotation and well-matched chiral purity via HPLC. Other amino alcohols we’ve made, such as simple phenylethanolamines, don’t hold a candle in terms of chiral economy in multi-step flows. Years of batch records and customer feedback point to reliable enantiomeric excess, with minimal batch-to-batch drift.

Model and Specifications—Focused On Synthetic Utility

We produce (1S,2R)-N-Benzyl-2-Amino-1,2-Diphenylethanol with experienced chemists overseeing each preparative and purification step. Typical product leaves our site as a free-flowing white solid. On request, we can supply detailed NMR, chiral HPLC, and mass spectra from our in-house QC lab. Each lot passes minimum thresholds for both chemical purity and stereochemical integrity, confirmed by experienced analysts—not just machine readouts. Large-scale pharmaceutical intermediates demand no less, and our processes reflect those standards.

Real-World Usage—From Lab Bench to Process Scale

We’ve worked directly with industrial and academic synthesis teams seeking robust, well-defined chiral intermediates for work such as API synthesis, process route development, and asymmetric catalysis studies. Time and again, (1S,2R)-N-Benzyl-2-Amino-1,2-Diphenylethanol steps in as a key scaffold for chiral resolution, or serves to anchor ligands or peptidomimetic segments through its sturdy functionalities. Especially in asymmetric hydrogenations or alkylations, its geometry blocks off undesired side products, allowing chemists to tune outcomes with confidence.

Process chemists value intermediates that won’t compromise workflow. Grease from isomeric mixtures or over-alkylation means lost time and solvent, so we built our methods to minimize these events. In our hands, this compound dissolves and reacts in a variety of common solvents—THF, methanol, DCM—for easy transfer from analytical runs to full-scale reactors. Whether you’re running pilot or moving hundreds of kilograms, the transition from process development to GMP production doesn’t throw surprises with this compound in the chain.

Comparing to Other Amino Alcohols—The Manufacturer’s Experience

There’s no end to similar-sounding intermediates in the chiral amino alcohol family, but not all offer the blend of reactivity, selectivity, and physical handling that process chemists want. We’ve prepared and scaled up alternatives such as (R)-phenylglycinol, (S)-leucinol, and racemic analogs for many partners. Those compounds have their place and come at different price points, but often lack either the N-benzyl driven substrate scope or the dual phenyl core that grants both rigidity and reactivity to (1S,2R)-N-Benzyl-2-Amino-1,2-Diphenylethanol.

In the labs here, selectivity during reductive amination or acylation consistently favors this product thanks to its well-mapped stereochemistry and steric profile. This translates directly into less side product formation, higher isolated yields, and cleaner workups downstream. Even at kilogram scale, chromatographic separation of unwanted isomers or byproducts stays manageable.

Some users have asked about replacing this intermediate with less-structured analogs to cut costs. Experience quickly shows that downstream losses make up the difference—and then some—in wasted input material, difficult purifications, and unpredictable batch variability. Years crafting and optimizing these chiral amino alcohols have taught us the hard-fought value of working with a rigorously defined, single-enantiomer compound.

Operational Details From Our Shop Floor

A lot of customer trust rides on each batch. To honor that, we maintain process transparency and control at every stage—beginning with chiral pool sourcing for starting material, right through to rotary evaporation, filtration, and final drying. Our tankage and filtration sections remain separate for each enantiomer line, further reducing any hint of cross-contamination.

Each production run tracks not only purity but trace flavor and residual solvents. It’s not about meeting a checklist, but about real downstream performance in synthesis. We invest in hands-on extractions and full spectra screening, since shortcuts lose their appeal when small impurities sideline a synthetic effort. That attention pays off when our partners uptake material to sensitive transformations without further reprocessing.

Steric Structure and Biological Applications

From experience, not every amino alcohol translates as smoothly into drug or advanced material development. This product’s N-benzyl and dual phenyl setup gives both synthetic utility in laboratory transformations and future compatibility with pharmacophore development. Its geometry fits a range of design motifs in medicinal chemistry, from beta-amino alcohol derived antihypertensives to scaffolds for CNS-active molecules. Some teams here have leveraged its reactive amine and secondary alcohol for divergent syntheses, flipping between amino protection or ring construction as project requirements shift.

Medicinal chemists appreciate the stability under mild conditions, allowing for stepwise protection and deprotection with minimal risk of racemization or elimination. Notably, we’ve seen strong performance in coupling approaches, whether by amide bond formation or urea installations. As an experienced manufacturer, we test new literature applications on small lots before scaling for customer use, passing along lessons learned back into our site processes.

Supply Security, Consistency, and Traceability

Our decades of production history taught us the direct impact that reliable sourcing and process transparency have on a synthetic campaign. Chiral intermediates walk a thin line between cost and quality—cut too many corners or chase savings in unvetted routes, and batch losses or time overruns crop up fast. We prequalify every raw material source, tracking chiral pool viability and running incoming QC at our own docks. Every batch’s journey remains archived for full regulatory and customer review.

Process integrity is a point of pride for us as manufacturers. It means lot-specific data packages, spectra, and full manufacturing logs remain linked to every shipment, accessible for partner audits or questions years down the line. Customers who have faced interruptions from other suppliers underscore the value here: consistency prevents costly surprises across multi-year programs.

Environmental Responsibility And Continuous Improvement

Synthetic chemistry sits at the center of progress, but we’ve seen how environmental and process sustainability shape the landscape for the long haul. Over multiple campaigns, we’ve worked to halve solvent consumption across several purification steps, and reclaim mother liquors where feasible. Purified water usage, waste handling, and energy balances are tracked on every production round. Improvements aren’t theoretical—they mean lower input costs for our partners and less regulatory risk when scaling up an API or advanced intermediate.

Our production team holds regular debriefs on process yields, safety events, and waste profiles. Solvent swaps and new workup methods often grow from technician-led ideas trialed on actual product. Sales pressure won’t override our established protocols for batch quality, containment, or trace impurity rejection. It’s not uncommon for us to revisit process steps after scale-up if customer specs or green chemistry initiatives demand.

Solutions and Troubleshooting—Insights From Hard-Won Experience

Batch reproducibility, scale-up consistency, and straightforward crystalline handling matter just as much as price or nominal purity. Over years of manufacturing (1S,2R)-N-Benzyl-2-Amino-1,2-Diphenylethanol, we’ve addressed all kinds of production issues directly—ranging from unexpected color formation due to oxidative contaminants, to crystal form transitions during drying. For each hurdle, our in-house chemists run root-cause investigations, adapting parameters and laying down process notes for future batches.

Handling guidelines we pass to customers grew from our own operational missteps. For instance, this product holds up against moderate air exposure, though best practice is to store in tightly sealed containers away from strong acids or bases. Extended exposure to sunlight can yellow the product, so we issue storage recommendations based on our own warehouse observations. Filtering and drying parameters are tuned based on glassware and tank experience, not just theory.

Building Trust—Why Manufacturers’ Insights Matter

Our connection to users isn’t just transactional; it’s built through corrective actions and transparent data sharing. When unusual NMR shifts, suspected impurities, or out-of-spec melting points crop up, we engage directly with our process teams, draw on archive samples, and perform the necessary extra screenings. Troubleshooting isn’t an abstract exercise. Every real-world issue solved goes back into our batch records and standard operating procedures, so future lots stay robust regardless of shifting team rosters or new plant installations.

Comparing our track record to other suppliers, direct manufacturer feedback shortens the lead time to resolution—something distributors or third-party traders simply can’t match. As chemists ourselves, we prize open dialogue with those driving route design and library preparation, because reliable supply and performance influence cost, time, and project outcomes.

Conclusion—A Chemist-To-Chemist Endorsement

The value of (1S,2R)-N-Benzyl-2-Amino-1,2-Diphenylethanol goes well beyond the typical chiral intermediate, due to both its precise chemical structure and the hard work behind each batch. From chiral pool manipulation and careful crystallization, to full transparency with users, our hands-on experience proves the difference between cutting corners and delivering consistent quality at scale. As manufacturing chemists, we vouch for this product’s utility—both as an enabler of complex syntheses and as a linchpin for efficient route development in research and production facilities worldwide.